Skip to main content
Top
Published in: Head & Neck Oncology 1/2009

Open Access 01-12-2009 | Research

Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis

Authors: Shruti Pandya, Ajay Kumar Chaudhary, Mamta Singh, Mangal Singh, Ravi Mehrotra

Published in: Head & Neck Oncology | Issue 1/2009

Login to get access

Abstract

Background

Oral submucous fibrosis is a common oral health problem in India. This study was conducted to correlate the histopathological diagnosis with habits and clinical findings in patients suffering from oral submucous fibrosis (OSF).

Methods

Patients suffering from oral submucous fibrosis from the Departments of Otorhinolayngology and Pathology, Moti Lal Nehru Medical College, Allahabad, India were studied from 2004–2008. Detailed information was gathered in a pretested proforma. Emphasis was given to the various addictions, clinical findings and histological examination was done.

Results

Two hundred and thirty nine patients were studied, yielding a male to female ratio of 6.8:1. Maximum patients were in the 21–30 years age group with a marked male predominance. Of these, 197 (82.4%) patients chewed areca nut/dohra, 14 (5.8%) were smokers and 2 (0.8%) patients were habituated to alcohol. 89(37.2%) patients reported difficulty in opening of the mouth (trismus). 51 (57.4%) patients were found to have stage II (2–3 cm) trismus while rest had stage I and III. The buccal mucosa was found to be the most commonly involved site. On the basis of histopathological examination, 52(21.7%) were classified as OSF grade I, 75(31.3%) patients as grade II and 112(46.8%) had grade III disease.

Conclusion

The widespread habit of chewing dohra/paan masala is a major risk factor of OSF, especially in the younger age group. In this study, an increase in histopathological grading was found with severity and duration of addiction habit. However no significant correlation was found between clinical staging and histopathological grading.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tilakratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S: Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol. 2005, 30: 30-32. Tilakratne WM, Klinikowski MF, Saku T, Peters TJ, Warnakulasuriya S: Oral submucous fibrosis: Review on aetiology and pathogenesis. Oral Oncol. 2005, 30: 30-32.
2.
go back to reference Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FS: A case-control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut. J Oral Pathol Med. 1990, 19: 94-98. 10.1111/j.1600-0714.1990.tb00804.x.CrossRefPubMed Sinor PN, Gupta PC, Murti PR, Bhonsle RB, Daftary DK, Mehta FS: A case-control study of oral submucous fibrosis with special reference to the aetiologic role of areca nut. J Oral Pathol Med. 1990, 19: 94-98. 10.1111/j.1600-0714.1990.tb00804.x.CrossRefPubMed
3.
go back to reference Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC: Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med. 1995, 24: 402-6. 10.1111/j.1600-0714.1995.tb01209.x.CrossRefPubMed Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC: Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med. 1995, 24: 402-6. 10.1111/j.1600-0714.1995.tb01209.x.CrossRefPubMed
4.
go back to reference Rajalalitha P, Vali S: Molecular pathogenesis of oral submucous fibrosis-a collagen metabolic disorder. J Oral Pathol Med. 2005, 34: 321-28. 10.1111/j.1600-0714.2005.00325.x.CrossRefPubMed Rajalalitha P, Vali S: Molecular pathogenesis of oral submucous fibrosis-a collagen metabolic disorder. J Oral Pathol Med. 2005, 34: 321-28. 10.1111/j.1600-0714.2005.00325.x.CrossRefPubMed
5.
go back to reference Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M: Prevalence of oral premalignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev. 2008, 9 (2): 263-265.PubMed Mehrotra R, Pandya S, Chaudhary AK, Kumar M, Singh M: Prevalence of oral premalignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev. 2008, 9 (2): 263-265.PubMed
6.
go back to reference Pindborg JJ, Odont , Sirsat SM: Oral submucous fibrosis. Oral Surg, Oral Med, Oral Pathol. 1966, 22: 764-79. 10.1016/0030-4220(66)90367-7.CrossRef Pindborg JJ, Odont , Sirsat SM: Oral submucous fibrosis. Oral Surg, Oral Med, Oral Pathol. 1966, 22: 764-79. 10.1016/0030-4220(66)90367-7.CrossRef
7.
go back to reference Reichart PA, Philipsen HP: Oral submucous fibrosis in a 31-year-old Indian women: first case report from Germany. Mund Kiefer Gesichtschir. 2006, 10 (3): 192-196. 10.1007/s10006-006-0671-7.CrossRefPubMed Reichart PA, Philipsen HP: Oral submucous fibrosis in a 31-year-old Indian women: first case report from Germany. Mund Kiefer Gesichtschir. 2006, 10 (3): 192-196. 10.1007/s10006-006-0671-7.CrossRefPubMed
8.
go back to reference Kumar KK, Saraswathi TR, Ranganathan K, Devi MU, Elizabeth J: Oral submucous fibrosis: A clinico-histopathological study in Chennai. Indian J Dent Res. 2007, 18: 106-11. 10.4103/0970-9290.33785.CrossRef Kumar KK, Saraswathi TR, Ranganathan K, Devi MU, Elizabeth J: Oral submucous fibrosis: A clinico-histopathological study in Chennai. Indian J Dent Res. 2007, 18: 106-11. 10.4103/0970-9290.33785.CrossRef
9.
go back to reference Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN: Oral submucous fibrosis: study of 1000 cases from Central India. J Oral Pathol Med. 2006, 35: 1-6. 10.1111/j.1600-0714.2005.00374.x.CrossRef Hazarey VK, Erlewad DM, Mundhe KA, Ughade SN: Oral submucous fibrosis: study of 1000 cases from Central India. J Oral Pathol Med. 2006, 35: 1-6. 10.1111/j.1600-0714.2005.00374.x.CrossRef
10.
go back to reference Zhang X, Reichart PA: A review of betel quid chewing, oral cancer and precancer in Mainland China. Oral Oncology. 2007, 43 (5): 424-30. 10.1016/j.oraloncology.2006.08.010.CrossRefPubMed Zhang X, Reichart PA: A review of betel quid chewing, oral cancer and precancer in Mainland China. Oral Oncology. 2007, 43 (5): 424-30. 10.1016/j.oraloncology.2006.08.010.CrossRefPubMed
11.
go back to reference Mehrotra R, Singh M, Kumar D, Pandey AN, Gupta RK, Sinha US: Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci. 2003, 57: 400-04.PubMed Mehrotra R, Singh M, Kumar D, Pandey AN, Gupta RK, Sinha US: Age specific incidence rate and pathological spectrum of oral cancer in Allahabad. Indian J Med Sci. 2003, 57: 400-04.PubMed
12.
go back to reference Babu S, Bhat RV, Kumar PU, et al: A comparative clinico-pathological study of oral submucous fibrosis in habitual chewers of pan masala and betelquid. J Toxicol Clin Toxicol. 1996, 34 (3): 317-22.CrossRefPubMed Babu S, Bhat RV, Kumar PU, et al: A comparative clinico-pathological study of oral submucous fibrosis in habitual chewers of pan masala and betelquid. J Toxicol Clin Toxicol. 1996, 34 (3): 317-22.CrossRefPubMed
13.
go back to reference Thomas G, Hashibe M, Jacob BJ, Ramadas K, Mathew B, Sankaranarayanan R, et al: Risk factors of multiple oral premaliganant lesions. Int J Cancer. 2003, 107: 285-91. 10.1002/ijc.11383.CrossRefPubMed Thomas G, Hashibe M, Jacob BJ, Ramadas K, Mathew B, Sankaranarayanan R, et al: Risk factors of multiple oral premaliganant lesions. Int J Cancer. 2003, 107: 285-91. 10.1002/ijc.11383.CrossRefPubMed
14.
go back to reference Ho PS, Yang YH, Shieh TY, Huang IY, Chen YK, Lin KN: Consumption of areca quid, cigarettes, and alcohol related to the comorbidity of oral submucous fibrosis and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 104 (5): 647-652. 10.1016/j.tripleo.2006.12.032.CrossRefPubMed Ho PS, Yang YH, Shieh TY, Huang IY, Chen YK, Lin KN: Consumption of areca quid, cigarettes, and alcohol related to the comorbidity of oral submucous fibrosis and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 104 (5): 647-652. 10.1016/j.tripleo.2006.12.032.CrossRefPubMed
15.
go back to reference Auluck A, Rosin MP, Zhang L: Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. J Can Dent Assoc. 2008, 74: 735-40.PubMed Auluck A, Rosin MP, Zhang L: Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature. J Can Dent Assoc. 2008, 74: 735-40.PubMed
16.
go back to reference Bhurgri Y: Cancer of the oral cavity – trends in Karachi South. Asian Pac J Cancer Prev. 2005, 6: 22-26.PubMed Bhurgri Y: Cancer of the oral cavity – trends in Karachi South. Asian Pac J Cancer Prev. 2005, 6: 22-26.PubMed
17.
go back to reference Reichart PA, Way TH: Oral cancer and pre-cancer in Myanmar: a short review. J Oral Pathol Med. 2006, 35: 193-6. 10.1111/j.1600-0714.2006.00390.x.CrossRefPubMed Reichart PA, Way TH: Oral cancer and pre-cancer in Myanmar: a short review. J Oral Pathol Med. 2006, 35: 193-6. 10.1111/j.1600-0714.2006.00390.x.CrossRefPubMed
18.
go back to reference Chiu CJ, Lee WC, Chiang CP, Hahen U, Kuo YS, Chen CJ: A scoring system for the early detection of oral sub mucous fibrosis based on a self administered questionnaires. J Pub Health Dentist. 2002, 62: 28-31. 10.1111/j.1752-7325.2002.tb03417.x.CrossRef Chiu CJ, Lee WC, Chiang CP, Hahen U, Kuo YS, Chen CJ: A scoring system for the early detection of oral sub mucous fibrosis based on a self administered questionnaires. J Pub Health Dentist. 2002, 62: 28-31. 10.1111/j.1752-7325.2002.tb03417.x.CrossRef
19.
go back to reference Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW: Role of areca nut in the causation of Oral submucous fibrosis: A case control study in Pakistan. J Oral Pathol Med. 1994, 23: 65-69. 10.1111/j.1600-0714.1994.tb00258.x.CrossRefPubMed Maher R, Lee AJ, Warnakulasuriya KA, Lewis JA, Johnson NW: Role of areca nut in the causation of Oral submucous fibrosis: A case control study in Pakistan. J Oral Pathol Med. 1994, 23: 65-69. 10.1111/j.1600-0714.1994.tb00258.x.CrossRefPubMed
20.
go back to reference Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta BC: Oral submucous fibrosis in India: A new epidemic?. Natl Med J India. 1998, 11 (3): 113-116.PubMed Gupta PC, Sinor PN, Bhonsle RB, Pawar VS, Mehta BC: Oral submucous fibrosis in India: A new epidemic?. Natl Med J India. 1998, 11 (3): 113-116.PubMed
21.
go back to reference Shah N, Sharma PP: Role of chewing and smoking habits in the aetiology of oral submucous fibrosis (OSF): a case control study. J Oral Pathol Med. 1998, 27: 475-79.CrossRefPubMed Shah N, Sharma PP: Role of chewing and smoking habits in the aetiology of oral submucous fibrosis (OSF): a case control study. J Oral Pathol Med. 1998, 27: 475-79.CrossRefPubMed
22.
go back to reference Sur TK, Biswas TK, Ali L, Mukherjee B: Anti-inflammatory and anti-platelet aggregation activity of human placental extract. Acta Pharmacol Sin. 2003, 24 (2): 187-92.PubMed Sur TK, Biswas TK, Ali L, Mukherjee B: Anti-inflammatory and anti-platelet aggregation activity of human placental extract. Acta Pharmacol Sin. 2003, 24 (2): 187-92.PubMed
23.
go back to reference Rajendran R, Rani V, Shaikh S: Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res. 2006, 17 (4): 190-8.CrossRefPubMed Rajendran R, Rani V, Shaikh S: Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian J Dent Res. 2006, 17 (4): 190-8.CrossRefPubMed
24.
go back to reference Haque MF, Meghji S, Nazir R, Harris M: Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathol Med. 2001, 30 (1): 12-21. 10.1034/j.1600-0714.2001.300103.x.CrossRefPubMed Haque MF, Meghji S, Nazir R, Harris M: Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis. J Oral Pathol Med. 2001, 30 (1): 12-21. 10.1034/j.1600-0714.2001.300103.x.CrossRefPubMed
25.
go back to reference Kumar A, Bagewadi A, Keluskar V, Singh M: Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 103 (2): 207-13. 10.1016/j.tripleo.2006.07.011.CrossRefPubMed Kumar A, Bagewadi A, Keluskar V, Singh M: Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007, 103 (2): 207-13. 10.1016/j.tripleo.2006.07.011.CrossRefPubMed
26.
go back to reference Nayak DR, Mahesh SG, Aggarwal D, Pavithran P, Pujary K, Pillai S: Role of KTP-532 laser in management of oral submucous fibrosis. J Laryngol Otol. 2008, 123 (4): 1-4. Nayak DR, Mahesh SG, Aggarwal D, Pavithran P, Pujary K, Pillai S: Role of KTP-532 laser in management of oral submucous fibrosis. J Laryngol Otol. 2008, 123 (4): 1-4.
Metadata
Title
Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis
Authors
Shruti Pandya
Ajay Kumar Chaudhary
Mamta Singh
Mangal Singh
Ravi Mehrotra
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Head & Neck Oncology / Issue 1/2009
Electronic ISSN: 1758-3284
DOI
https://doi.org/10.1186/1758-3284-1-10

Other articles of this Issue 1/2009

Head & Neck Oncology 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine